These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 762792)

  • 21. [The quantities of main urinary metabolite of PGF, plasma PGF and plasma PGE in pulmonary diseases].
    Takahashi W
    Hokkaido Igaku Zasshi; 1982 May; 57(3):303-15. PubMed ID: 7129348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of renal prostaglandins in the nephrotic syndrome.
    Ruilope L; Millet VG; Alcazar JM; Prieto C; Tresguerres JA; Garcia-Robles R; Sancho J; Rodicio JL
    Proc Eur Dial Transplant Assoc; 1983; 19():738-43. PubMed ID: 6576332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndrome.
    Tiggeler RG; Koene RA; Wijdeveld PG
    Clin Sci Mol Med; 1977 Feb; 52(2):149-51. PubMed ID: 844248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of anti-inflammatory drugs on urinary excretion of prostaglandin metabolites in cotton pellet inflammation.
    Yamada K; Aizawa Y
    Eur J Pharmacol; 1983 May; 90(1):91-5. PubMed ID: 6873179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of renal prostaglandins in sympathetically mediated renin relase in the rat.
    Campbell WB; Graham RM; Jackson EK
    J Clin Invest; 1979 Aug; 64(2):448-56. PubMed ID: 37256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of renal prostaglandin E as a possible modulator of cyclic AMP production in nephrotic syndrome.
    Túri S; Havass Z; Bodrogi T
    Int Urol Nephrol; 1986; 18(3):321-5. PubMed ID: 3021645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indomethacin-responsive pancreatic cholera.
    Jaffe BM; Kopen DF; DeSchryver-Kecskemeti K; Gingerich RL; Greider M
    N Engl J Med; 1977 Oct; 297(15):817-21. PubMed ID: 197410
    [No Abstract]   [Full Text] [Related]  

  • 28. Furosemide induced release of prostaglandin E to increase renal blood flow.
    Williamson HE; Bourland WA; Marchand GR; Farley DB; Van Orden DE
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):104-6. PubMed ID: 1187679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study.
    Vriesendorp R; Donker AJ; de Zeeuw D; de Jong PE; van der Hem GK
    Am J Nephrol; 1985; 5(4):236-42. PubMed ID: 3901756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary prostaglandins in kidney disease.
    Papanicolaou N; Mountokalakis T; Palassides A; Paris M; Bariety J; Papavassiliou J; Merikas G; Milliez P
    Prostaglandins Med; 1979 Jul; 3(1):47-51. PubMed ID: 552098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin inhibitors in the treatment of nephrotic syndrome.
    Bergstein JM
    Pediatr Nephrol; 1991 May; 5(3):335-8. PubMed ID: 1867990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of prostaglandins biosynthesis lowers antidiuretic hormone excretion in man.
    Glasson P; Vallotton MB
    Adv Prostaglandin Thromboxane Res; 1980; 7():1115-8. PubMed ID: 6989179
    [No Abstract]   [Full Text] [Related]  

  • 33. Dependence of plasma renin activity on protaglandin excretion in essential hypertension.
    Ylitalo P; Vapaatalo H; Metsä-Ketelä T; Pitkäjärvi T
    Acta Physiol Scand; 1978 Jan; 102(1):120-2. PubMed ID: 626085
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac.
    Zambraski EJ; Dodelson R; Guidotti SM; Harnett CA
    Med Sci Sports Exerc; 1986 Dec; 18(6):678-84. PubMed ID: 3537627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin.
    Pomeranz A; Wolach B; Bernheim J; Korzets Z; Bernheim J
    J Pediatr; 1995 Jan; 126(1):140-2. PubMed ID: 7815205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Uterine prostaglandins and dysmenorrhea].
    Seifert B; Liedtke MP
    Zentralbl Gynakol; 1978; 100(21):1361-6. PubMed ID: 735539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction of increased prostacyclin production in Bartter's syndrome by indomethacin.
    Güllner HG; Cerletti C; Bartter FC; Gill JR; Smith JB
    Trans Assoc Am Physicians; 1980; 93():130-40. PubMed ID: 7018063
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
    Hsieh BS; Chen WY; Yen TS; Lai MS
    Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indomethacin in the therapy of prolonged or chronic glomerulonephritis and of the nephrotic syndrome].
    Campanacci L; Gambari P; Castellani A; Huber W
    Clin Ter; 1972 Apr; 61(1):31-46. PubMed ID: 5039599
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of time and dose of indomethacin on follicular prostaglandins and ovulation in the rabbit.
    Espey LL; Norris C; Saphire D
    Endocrinology; 1986 Aug; 119(2):746-54. PubMed ID: 3732143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.